0.9299
price up icon0.53%   0.0049
after-market Handel nachbörslich: .93 0.0001 +0.01%
loading

Clearside Biomedical Inc Aktie (CLSD) Neueste Nachrichten

pulisher
Jan 15, 2025

Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Significant Decline in Short Interest - MarketBeat

Jan 15, 2025
pulisher
Jan 11, 2025

Geode Capital Management LLC Buys 59,089 Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World

Jan 11, 2025
pulisher
Jan 11, 2025

Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives $5.33 Average Price Target from Analysts - MarketBeat

Jan 11, 2025
pulisher
Jan 11, 2025

Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Average Rating of “Buy” by Analysts - Defense World

Jan 11, 2025
pulisher
Dec 26, 2024

Clearside Biomedical (NASDAQ:CLSD) Stock Price Crosses Below 50-Day Moving Average – Here’s Why - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

Clearside Biomedical (NASDAQ:CLSD) Shares Pass Below 50 Day Moving AverageWhat's Next? - MarketBeat

Dec 26, 2024
pulisher
Dec 21, 2024

Further weakness as Clearside Biomedical (NASDAQ:CLSD) drops 14% this week, taking five-year losses to 72% - Simply Wall St

Dec 21, 2024
pulisher
Dec 20, 2024

Clearside Biomedical stock hits 52-week low at $0.92 By Investing.com - Investing.com South Africa

Dec 20, 2024
pulisher
Dec 20, 2024

Clearside Biomedical stock hits 52-week low at $0.92 - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

Clearside announces publication of insights on drug development, regulation - Yahoo Finance

Dec 20, 2024
pulisher
Dec 20, 2024

Analyst Sees 500% Upside for This Pharmaceutical Penny Stock - GuruFocus.com

Dec 20, 2024
pulisher
Dec 19, 2024

Clearside Biomedical Announces Publication of Critical - GlobeNewswire

Dec 19, 2024
pulisher
Dec 19, 2024

Clearside Biomedical Unveils Groundbreaking Insights on Retinal Drug Development in Eye Journal - StockTitan

Dec 19, 2024
pulisher
Dec 17, 2024

Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

Brokerages Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Price Target at $5.33 - MarketBeat

Dec 17, 2024
pulisher
Dec 16, 2024

Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now - MSN

Dec 16, 2024
pulisher
Dec 16, 2024

Clearside Biomedical's SWOT analysis: innovative eye treatment stock faces pivotal trial - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Down 11.8% in November - MarketBeat

Dec 16, 2024
pulisher
Dec 12, 2024

Clearside Biomedical (NASDAQ:CLSD) Upgraded to Hold at StockNews.com - MarketBeat

Dec 12, 2024
pulisher
Dec 04, 2024

Clearside Biomedical's SWOT analysis: stock poised for potential breakthrough in wet AMD treatment - Investing.com Nigeria

Dec 04, 2024
pulisher
Dec 03, 2024

Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Down 13.6% in November - Defense World

Dec 03, 2024
pulisher
Dec 01, 2024

Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Large Decrease in Short Interest - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

Clearside Biomedical (FRA:CLM) Momentum Rank : 5 (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024
pulisher
Nov 26, 2024

Clearside showcases eye therapy delivery tech By Investing.com - Investing.com South Africa

Nov 26, 2024
pulisher
Nov 25, 2024

Clearside showcases eye therapy delivery tech - Investing.com

Nov 25, 2024
pulisher
Nov 25, 2024

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States - The Manila Times

Nov 25, 2024
pulisher
Nov 25, 2024

Clearside Biomedical Extends Global Footprint with Numerous - GlobeNewswire

Nov 25, 2024
pulisher
Nov 22, 2024

Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Nov 22, 2024
pulisher
Nov 22, 2024

Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Nov 22, 2024
pulisher
Nov 21, 2024

Clearside Biomedical (FRA:CLM) Financial Strength : 4 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 20, 2024

Crude Oil Brent (SCU24) Quote - The Globe and Mail

Nov 20, 2024
pulisher
Nov 18, 2024

Clearside Biomedical’s (CLSD) Buy Rating Reaffirmed at HC Wainwright - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

What is HC Wainwright’s Forecast for CLSD FY2024 Earnings? - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

What is HC Wainwright's Forecast for CLSD FY2024 Earnings? - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

Clearside Biomedical's (CLSD) Buy Rating Reaffirmed at Chardan Capital - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Clearside Biomedical (NASDAQ:CLSD) Stock Rating Upgraded by StockNews.com - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy - MSN

Nov 16, 2024
pulisher
Nov 15, 2024

Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Needham & Company LLC Reaffirms Buy Rating for Clearside Biomedical (NASDAQ:CLSD) - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Clearside Biomedical Announces Slight Revenue Increase in Third Quarter, Advances Wet AMD Treatment in Clinical Trial - Vision Monday

Nov 14, 2024
pulisher
Nov 13, 2024

Earnings call: Clearside Biomedical reports progress in AMD treatment - Investing.com

Nov 13, 2024
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
Kapitalisierung:     |  Volumen (24h):